Feedback / Questions
Cylembio (imsapepimut and etimupepimut, adjuvanted) - IO Biotech
https://in.investing.com/news/stock-market-news/io-biotech-stock-slumps-after-trial-of-cancer-therapy-plus-keytruda-misses-study-goal-retail-sees-shares-rise-10x-4956525
Aug 11, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next